rxstat › Prices in New Brunswick › Adalimumab

Adalimumab (Humira) price and coverage in New Brunswick

Adalimumab 40 mg/0.8ml solution lists at $471.27 per syringe in New Brunswick on the New Brunswick Drug Plans' price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Adalimumab is covered by the New Brunswick Drug Plans only under Special Authorization: your prescriber has to request coverage, and it applies to patients who meet set criteria.

Price by strength in New Brunswick

Strength and formLowest priceBrand
40 mg/0.8ml Solution10 products · special approval$471.27/syringe–
40 mg/0.4ml Solution8 products · special approval$471.27/syringe–
80 mg/0.8ml Solution5 products · special approval$942.54/syringe–
20 mg/0.4ml Solution3 products · special approval$235.63/syringe–
50 mg/ml Solution3 products · special approval$235.64/syringe–
20 mg/0.2ml Solution1 product · special approval$235.63/syringe–
All 30 products listed in New Brunswick
ProductPriceCoverage
40 mg/0.8ml Solution
HadlimaORG · DIN 02473097$471.27/syringeSpecial approval
Hadlima PushtouchORG · DIN 02473100$471.27/autoinjectorSpecial approval
HyrimozSDZ · DIN 02492156$471.27/autoinjectorSpecial approval
HyrimozSDZ · DIN 02492164$471.27/syringeSpecial approval
HulioBIL · DIN 02502399$471.27/syringeSpecial approval
HulioBIL · DIN 02502402$471.27/autoinjectorSpecial approval
IdacioFKB · DIN 02502674$471.27/autoinjectorSpecial approval
IdacioFKB · DIN 02502682$471.27/syringeSpecial approval
AbriladaPFI · DIN 02511045$471.27/autoinjectorSpecial approval
AbriladaPFI · DIN 02511053$471.27/syringeSpecial approval
40 mg/0.4ml Solution
YuflymaCLT · DIN 02523760$471.27/syringeSpecial approval
YuflymaCLT · DIN 02523779$471.27/autoinjectorSpecial approval
SimlandiJPC · DIN 02523949$471.27/syringeSpecial approval
SimlandiJPC · DIN 02523957$471.27/autoinjectorSpecial approval
HadlimaORG · DIN 02533472$471.27/syringeSpecial approval
Hadlima PushtouchORG · DIN 02533480$471.27/autoinjectorSpecial approval
HyrimozSDZ · DIN 02542323$471.27/syringeSpecial approval
HyrimozSDZ · DIN 02542331$471.27/autoinjectorSpecial approval
80 mg/0.8ml Solution
SimlandiJPC · DIN 02523965$942.54/syringeSpecial approval
YuflymaCLT · DIN 02535076$942.54/syringeSpecial approval
YuflymaCLT · DIN 02535084$942.54/autoinjectorSpecial approval
HyrimozSDZ · DIN 02542358$942.54/syringeSpecial approval
HyrimozSDZ · DIN 02542366$942.54/autoinjectorSpecial approval
20 mg/0.4ml Solution
AbriladaPFI · DIN 02511061$235.63/syringeSpecial approval
HulioBIL · DIN 02502380$235.63/syringeSpecial approval
HyrimozSDZ · DIN 02505258$235.63/syringeSpecial approval
50 mg/ml Solution
AmgevitaAGA · DIN 02459310$235.64/syringeSpecial approval
AmgevitaAGA · DIN 02459299$471.27/syringeSpecial approval
AmgevitaAGA · DIN 02459302$471.27/autoinjectorSpecial approval
20 mg/0.2ml Solution
HyrimozSDZ · DIN 02542315$235.63/syringeSpecial approval

What you'll pay at the pharmacy

These are the prices the New Brunswick Drug Plans lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.

Shortage status

Partial shortage Supply is affected in Canada: see shortage status.

Adalimumab price in other provinces

Common questions

How much does Adalimumab cost in New Brunswick?

Adalimumab 40 mg/0.8ml solution lists at $471.27 per syringe in New Brunswick on the New Brunswick Drug Plans' price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Is Adalimumab covered in New Brunswick?

Adalimumab is covered by the New Brunswick Drug Plans only under Special Authorization: your prescriber has to request coverage, and it applies to patients who meet set criteria.

Is Adalimumab cheaper in another province?

For 40 mg/0.8ml solution, listed prices run from $471.27 to $471.27 across 4 provinces. Public plans only cover their own residents, though.

Source: New Brunswick Drug Plans Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.